250 related articles for article (PubMed ID: 37138341)
1. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract][Full Text] [Related]
2. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study.
Veiga LHS; Vo JB; Curtis RE; Mille MM; Lee C; Ramin C; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Lancet Oncol; 2022 Nov; 23(11):1451-1464. PubMed ID: 36240805
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
4. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
5. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
Sung H; Freedman RA; Siegel RL; Hyun N; DeSantis CE; Ruddy KJ; Jemal A
Cancer; 2021 Sep; 127(18):3310-3324. PubMed ID: 34002851
[TBL] [Abstract][Full Text] [Related]
6. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
[TBL] [Abstract][Full Text] [Related]
7. Second primary breast cancer occurrence according to hormone receptor status.
Kurian AW; McClure LA; John EM; Horn-Ross PL; Ford JM; Clarke CA
J Natl Cancer Inst; 2009 Aug; 101(15):1058-65. PubMed ID: 19590058
[TBL] [Abstract][Full Text] [Related]
8. Risks of second malignancies after breast cancer treatment: Long-term results.
Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
[TBL] [Abstract][Full Text] [Related]
9. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
10. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
11. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
12. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis.
Allen I; Hassan H; Sofianopoulou E; Eccles D; Turnbull C; Tischkowitz M; Pharoah P; Antoniou AC
Breast Cancer Res; 2023 Feb; 25(1):18. PubMed ID: 36765408
[TBL] [Abstract][Full Text] [Related]
13. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
14. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of second cancers following breast cancer: role of the initial treatment.
Rubino C; de Vathaire F; Diallo I; Shamsaldin A; Lê MG
Breast Cancer Res Treat; 2000 Jun; 61(3):183-95. PubMed ID: 10965995
[TBL] [Abstract][Full Text] [Related]
16. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
Bright CJ; Hawkins MM; Winter DL; Alessi D; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Byrne J; Feijen EAM; Fidler MM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuehni CE; Linge H; Øfstaas H; Ronckers CM; Skinner R; Teepen JC; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuonen R; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Reulen RC;
J Natl Cancer Inst; 2018 Jun; 110(6):649-660. PubMed ID: 29165710
[TBL] [Abstract][Full Text] [Related]
17. Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective.
Guzzinati S; Buja A; Grotto G; Zorzi M; Manfredi M; Bovo E; Del Fiore P; Tropea S; Dall'Olmo L; Rossi CR; Mocellin S; Rugge M
Front Public Health; 2023; 11():1195458. PubMed ID: 37397750
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Risk of Subsequent Malignant Neoplasms Among Childhood and Adolescent Lymphoma Survivors (1975-2013): A Population-Based Predictive Nomogram.
Liu J; Zheng Q; Beeraka NM; Zhang X; Li T; Song R; Zhao D; Fan R
Oncologist; 2023 Sep; 28(9):e765-e773. PubMed ID: 37177980
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.
Andersson M; Jensen MB; Engholm G; Henrik Storm H
Acta Oncol; 2008; 47(4):755-64. PubMed ID: 18465345
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
